Parallax Volatility Advisers, L.P. Adaptimmune Therapeutics PLC Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$3.76 - $14.16 $114,172 - $429,968	-30,365 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$8.27 - $13.56 $248,637 - $407,681	30,065 Added 10021.67%	30,365 $412,000
Q2 2018 Aug 14, 2018	SELL	$10.42 - $13.74 $10,420 - $13,740	-1,000 Reduced 76.92%	300 $4,000
Q1 2018 May 15, 2018	BUY	$7.1 - $11.56 $9,230 - $15,028	1,300 New	1,300 $15,000

150M

60.8K

5.8K

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $98M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.